Related Experiment Video

Updated: May 14, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Identification of driver mutations in lung cancer: first step in personalized cancer

David Planchard1

  • 1Department of Medical Oncology (Thoracic Unit), Institut-Gustave-Roussy, 114 rue Edouard Vaillant, 94805, Villejuif Cedex, France. David.PLANCHARD@igr.fr

Targeted Oncology
|February 2, 2013
PubMed

Insights

Personalized medicine is revolutionizing non-small cell lung cancer (NSCLC) treatment. Molecular profiling identifies specific targets, enabling tailored therapies for distinct NSCLC subtypes, improving patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Non-small cell lung cancer (NSCLC) exhibits diverse molecular characteristics influencing carcinogenesis and treatment response.
  • Targeted therapies are effective when directed at specific molecular alterations within patient subpopulations.
  • Identifying molecular targets is crucial for advancing personalized medicine in NSCLC.

Purpose of the Study:

  • To highlight the shift towards personalized medicine in NSCLC management.
  • To emphasize the importance of molecular profiling in identifying therapeutic targets.
  • To underscore the concept of NSCLC as a group of distinct diseases based on molecular profiles.

Main Methods:

  • Review of current research on NSCLC molecular alterations.
  • Analysis of the role of targeted therapies in relation to specific mutations (e.g., EGFR, EML4-ALK).
  • Discussion of the impact of molecular profiling technologies on treatment strategies.

Main Results:

  • NSCLC is increasingly recognized as a heterogeneous disease with unique biological behaviors.
  • Specific molecular alterations (driver mutations) like EGFR and EML4-ALK are key targets for therapy.
  • Novel signaling pathways are emerging as targets for lung cancer treatment.

Conclusions:

  • The management of NSCLC is transitioning to an era of personalized medicine.
  • Molecular profiling of DNA is essential for tailoring medical care to individual NSCLC patients.
  • Viewing NSCLC as a collection of rare diseases based on molecular profiles optimizes treatment selection.

More Related Videos

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...